Organization
Hua Medicine
3 clinical trials
Clinical trial
A Multicenter Post-Marketing Observational Study to Evaluate the Long-Term Safety of Dorzagliatin in Patients With Type 2 Diabetes MellitusStatus: Recruiting, Estimated PCD: 2026-04-30
Clinical trial
A Phase 1, Open-Label, Sequential, Multiple-Dose, Drug-Drug Interaction Study of Dorzagliatin and Sitagliptin in Subjects With Type 2 Diabetes MellitusStatus: Completed, Estimated PCD: 2019-08-30
Clinical trial
An Open-Label, Paralleled Study of the Pharmacokinetics of HMS5552 Following a Single Oral Dose in Mild and Moderate Hepatic Impaired Subjects and Matched Healthy VolunteersStatus: Completed, Estimated PCD: 2020-07-03